/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Benitec Biopharma Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$12.62 0.0798(7.98%) BNTC at 04 Dec 2025 04:27 PM Biotechnology
Lowest Today 11.65
Highest Today 12.94
Today’s Open 11.65
Prev. Close 11.65
52 Week High 17.15
52 Week Low 9.49
Day’s Range: Low 11.65 High 12.94
52-Week Range: Low 9.49 High 17.15
1 day return -
1 Week return -3.86
1 month return -20.81
3 month return -11.07
6 month return -20.0
1 year return +24.64
3 year return +320.07
5 year return -73.77
10 year return -

Institutional Holdings

Suvretta Capital Management, LLC 37.62

HHG PLC 11.06

Franklin Resources Inc 10.29

Adage Capital Partners Gp LLC 7.51

Franklin Biotechnology Discv A(acc)USD 5.70

HBM Healthcare Investments AG Ord 4.54

Franklin Biotechnology Discovery A 4.38

Vanguard Group Inc 3.69

Nantahala Capital Management, LLC 3.19

BlackRock Inc 2.74

Vanguard Total Stock Mkt Idx Inv 1.89

Janus Henderson Hrzn Biotec E2 USD 1.62

Geode Capital Management, LLC 1.58

iShares Russell 2000 ETF 1.23

Schonfeld Strategic Advisors LLC 0.99

SILVERARC CAPITAL MANAGEMENT, LLC 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.89

State Street Corp 0.61

Fidelity Small Cap Index 0.55

Awm Investment Company Inc 0.53

Northern Trust Corp 0.48

iShares Russell 2000 Growth ETF 0.47

Fidelity Extended Market Index 0.44

Ameriprise Financial Inc 0.42

MEDICAL BioHealth EUR Acc 0.35

ExodusPoint Capital Management, LP 0.29

Vanguard Russell 2000 ETF 0.26

Simplify Asset Management Inc. 0.26

Simplify Health Care ETF 0.26

MYDA Advisors LLC 0.24

Lion Point Capital, LP 0.24

Longaeva Partners L.P. 0.20

State St Russell Sm Cap® Indx SL Cl I 0.19

Charles Schwab Investment Management Inc 0.17

Extended Equity Market Fund K 0.16

RIM Global Bioscience EUR 0.16

Fidelity Total Market Index 0.15

Schwab Small Cap Index 0.14

NT R2000 Index Fund - NL 0.13

iShares Micro-Cap ETF 0.13

Market Status

Strong Buy: 4

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 394.49 M

PB Ratio 4.6887

PE Ratio 0.0

Enterprise Value 345.19 M

Total Assets 99.59 M

Volume 816859

Company Financials

Annual Revenue FY25:0 0.0M, FY24:216000 0.2M, FY23:75000 0.1M, FY22:73000 0.1M, FY21:59000 0.1M

Annual Profit FY25:-396000 -0.4M, FY24:108000 0.1M, FY23:75000 0.1M, FY22:64000 0.1M, FY21:-64000 -0.1M

Annual Net worth FY25:-37917000 -37.9M, FY24:-21751000 -21.8M, FY23:-19562000 -19.6M, FY22:-18562000 -18.6M, FY21:-13781000 -13.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:556000 0.6M, Q1/2025:0 0.0M, Q4/2024:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:-178522 -0.2M, Q2/2025:278000 0.3M, Q1/2025:-106000 -0.1M, Q4/2024:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q3/2025:-13563148 -13.6M, Q2/2025:-16147000 -16.1M, Q1/2025:-9354000 -9.4M, Q4/2024:-7357000 -7.4M, Q3/2024:-5059000 -5.1M

Fund house & investment objective

Company Information Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Dr. Jerel A. Banks M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow